Featured Research

from universities, journals, and other organizations

Researchers Create Lung Cancer 'Cluster Bombs'

Date:
January 30, 2004
Source:
University Of Alberta
Summary:
The butcher, the baker, and the candlestick maker may be more famous, but the pharmacist, the engineer, and the doctor may be onto something big. The latter group has combined resources and knowledge to create a novel way to deliver a new lung cancer treatment. The new system, which uses "nanoparticle cluster bombs," has proven effective in treating cancerous lung cells in vitro.

The butcher, the baker, and the candlestick maker may be more famous, but the pharmacist, the engineer, and the doctor may be onto something big.

The latter group has combined resources and knowledge to create a novel way to deliver a new lung cancer treatment. The new system, which uses "nanoparticle cluster bombs," has proven effective in treating cancerous lung cells in vitro (in a petri dish), it was reported today in the International Journal of Pharmaceuticals. The research team from the University of Alberta will conduct in vivo tests (in live specimens) early this year, with plans for clinical trials to follow.

"Based on what we've been able to do so far, we have practical hopes that a new lung delivery platform for lung cancer can be established," said Dr. Raimar Loebenberg, a professor of pharmacy at the U of A.

The three researchers--Loebenberg; Dr. Warren Finlay, a U of A mechanical engineering professor; and Dr. Wilson Roa, a U of A oncology professor--have applied for a patent on the lung cancer nanoparticle drug delivery system.

Loebenberg explained that the drug sits in powder form in the inhaler, which is similar to the device that asthmatics use. However, the difference between regular drugs and "nanoparticle cluster bombs," Loebenberg said, comes when the powder arrives in the lungs, where it dissolves into nanoparticles upon contact with moisture in the lung--usually mucous.

Each grain of drug powder contains "a few thousand nanoparticles," Finlay explained. "Once the nanoparticles are active in the lung they have a tremendous advantage over regular drugs, because they are better able to do exactly what we want them to."

The idea is that the nanoparticles can be programmed to escape immune system surveillance like a Trojan Horse, and carry designer drugs that target cancer cells while leaving healthy cells alone.

"This drug and this delivery system have a lot of potential--there are a lot of different things we can do as we're able to control where and when the nanoparticles release their payload," said Finlay, who also has a patent pending on a new inhaler to go with the nanoparticle drug platform. "This platform system may be just the beginning. We're looking at a lot of cool things we can do down the road."

"At this point, we're excited and encouraged about what we've done and what we could do in the future," Loebenberg said, adding that the progress is due to the interdisciplinary collaboration between experts in three fields.

"This was not the result of one brain, but three," he said. "At first, when we started working together we didn't understand each other very well, but now I think we make a pretty good team, and I think we've created something that has good potential for a solution to lung cancer."


Story Source:

The above story is based on materials provided by University Of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University Of Alberta. "Researchers Create Lung Cancer 'Cluster Bombs'." ScienceDaily. ScienceDaily, 30 January 2004. <www.sciencedaily.com/releases/2004/01/040130074248.htm>.
University Of Alberta. (2004, January 30). Researchers Create Lung Cancer 'Cluster Bombs'. ScienceDaily. Retrieved April 20, 2014 from www.sciencedaily.com/releases/2004/01/040130074248.htm
University Of Alberta. "Researchers Create Lung Cancer 'Cluster Bombs'." ScienceDaily. www.sciencedaily.com/releases/2004/01/040130074248.htm (accessed April 20, 2014).

Share This



More Health & Medicine News

Sunday, April 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Nine-Month-Old Baby Can't Open His Mouth

Nine-Month-Old Baby Can't Open His Mouth

Newsy (Apr. 19, 2014) Nine-month-old Wyatt Scott was born with a rare disorder called congenital trismus, which prevents him from opening his mouth. Video provided by Newsy
Powered by NewsLook.com
'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins